drugset / Trial / NCT00171288

Efficacy and Safety Study of Fluvastatin and Ezetimibe Combined Versus Fluvastatin Alone

NCT00171288

Phase 3 Completed 83 enrolled Novartis
RandomizedParallel-groupOpen-labelTreatment

Summary

The objective of this study is to assess the effect of the combination treatment on C-reactive protein and inflammatory markers as well as the safety and tolerability in a Spanish population

Timeline

Start
2003-08
Primary completion
2005-08
Completion
2005-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Ezetimibe Unknown
Background Fluvastatin Other / unclassified

Indications